Irbaz Bin Riaz

Integrating large language models in systematic reviews: a framework and case study using ROBINS-I for risk of bias assessment

2024 · 56 Zit. · BMJ evidence-based medicine

Collaborative large language models for automated data extraction in living systematic reviews

2025 · 32 Zit. · Journal of the American Medical Informatics Association

Artificial intelligence across the cancer care continuum

2025 · 17 Zit. · Cancer

Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy

2024 · 17 Zit. · Frontiers in Oncology

Potential application of artificial intelligence in cancer therapy

2024 · 15 Zit. · Current Opinion in Oncology

Empirical evaluation of language modeling to ascertain cancer outcomes from clinical text reports

2023 · 12 Zit. · BMC Bioinformatics

Collaborative Large Language Models for Automated Data Extraction in Living Systematic Reviews

2024 · 7 Zit. · medRxiv

Do it faster with PICOS: Generative AI-Assisted systematic review screening

2025 · 6 Zit. · Journal of Biomedical Informatics

The Current Application and Future Potential of Artificial Intelligence in Renal Cancer

2024 · 4 Zit. · Urology

Performance of ChatGPT-4 and Bard Chatbots in Responding to Common Patient Questions on Prostate Cancer 177Lu-PSMA-617 Therapy

2023 · 2 Zit. · Research Square

Empirical evaluation of artificial intelligence distillation techniques for ascertaining cancer outcomes from electronic health records

2025 · 1 Zit. · npj Digital Medicine

Large language models (LLMs) for inferring genomic characteristics and facilitating genomic literacy in prostate cancer (PCa) patients.

2025 · 1 Zit. · Journal of Clinical Oncology

Reimagining Cancer Care With Generative Artificial Intelligence: The Promise of Large Language Models

2025 · 1 Zit. · JCO Clinical Cancer Informatics

Transforming Cardio-Oncology Care Through AI-Driven Large Language Model Systems

2025 · 1 Zit. · JACC Advances

A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).

2021 · 1 Zit. · Journal of Clinical Oncology